Iris Arteriovenous Malformation

An iris AVM is an abnormal shortcut (shunt) between an iris artery and an iris vein. Instead of blood flowing from arteries → tiny capillaries → veins, the artery and vein connect directly, creating a loop or tangle of unusually large, twisty vessels on the colored part of your eye (the iris). It’s benign (not cancer) and usually present from birth (congenital), even if no one notices it until adulthood. Most cases are isolated to the eye, with no known systemic disease links and typically stay stable over time. EyeWikiPubMedd1xe7tfg0uwul9.cloudfront.net

How it looks to the eye doctor: On the slit-lamp microscope, it often appears as a single, thick, tortuous blood vessel snaking across the iris, sometimes looping near the angle (the drainage area). Dye tests like fluorescein angiography show early filling of that vessel but usually no leakage, which helps distinguish it from true vascular tumors. PubMedajo.com

---

Types

Because this is a malformation (a developmental wiring variant), doctors “type” iris AVM mostly by appearance and extent, not by stages like a tumor.

1. Single-loop (simple) AVM
   A single large, twisty vessel runs across part of the iris—by far the most common look. Often unilateral (one eye), stable, and found incidentally. PubMed

2. Nidus-type (tangle) AVM
   A small knot (nidus) of vessels marks the direct artery-to-vein join, with one or more feeding and draining vessels. It still behaves benignly. EyeWiki

3. Racemose variant
   “Racemose hemangioma” is the older nickname; it simply means a prominent arteriovenous connection without a capillary bed. Imaging shows fast in-out flow and typically no dye leakage. ajo.com

4. Sectoral vs. diffuse
   Most lesions are sectoral (limited to one region). Diffuse involvement of the whole iris is rare; if suspected, doctors look hard for mimics. PubMed

5. Associated angle loop
   Sometimes the large vessel dives into or arises from the angle (seen on gonioscopy), which matters for surgery planning or if pressure rises. d1xe7tfg0uwul9.cloudfront.net

(Note: Other iris vascular entities—microhemangiomatosis (vascular tufts) and iris varix—are not types of AVM; they’re different benign conditions but important look-alikes. AVM tends to have a big, early-filling vessel with no leakage; microhemangiomatosis often causes spontaneous hyphema much more often; varix is a dilated vein that can mimic a mass. Your clinician separates them with dye tests and OCT-angiography.) PubMed Centralmorancore.utah.eduEyeWiki

---

Causes

The honest truth: For true iris AVM, the “cause” is developmental—the blood vessels of the iris formed with a direct artery-vein connection before birth. There are no proven lifestyle, diet, infection, or systemic triggers unique to iris AVM, and no routine systemic associations have been shown in the largest series. Because you asked for a detailed list, here’s a careful breakdown of 20 contributor-style explanations that clinicians discuss. Items 1–8 are the core, evidence-backed reasons; items 9–20 are context points that either (a) explain visibility/recognition over time or (b) cover mimics that are sometimes mistakenly labeled “cause” until imaging proves otherwise.

1. Congenital arteriovenous shunt: The primary reason—artery and vein connected directly during eye development. EyeWiki

2. Absence of capillary bed: The capillary “middle step” never formed in that small segment of iris. EyeWiki

3. Isolated ocular anomaly: In most series, iris AVM appears without systemic disease. PubMed

4. Benign vascular architecture: It’s not a tumor; it’s an anatomic variant. EyeWiki

5. Unilateral presentation: Often only one eye develops the malformation, supporting a localized developmental event. PubMed

6. Stationary natural history: Most stay stable for years, which fits a fixed congenital pattern. PubMed

7. Arterialization of a vein near the angle: The shunt can make a venous segment look thick and pulsatile near the drainage area. d1xe7tfg0uwul9.cloudfront.net

8. Racemose pattern: A classic AVM architecture recognized in many body sites, also seen in the iris. EyeWiki

9. Late recognition: It may be noticed in mid-life simply because of a routine eye exam, not because it “developed” then. PubMed

10. Dilation and better microscopes: Pharmacologic dilation and modern slit-lamps make the vessel easier to see. (General clinical observation; aligns with series noting incidental detection.) PubMed

11. Imaging availability: FA/ICG/OCT-A now highlight these vessels more clearly than in the past. BioMed Central

12. Trauma/surgery unmasking: Minor trauma or surgery can draw attention (e.g., a small bleed), revealing a pre-existing AVM. (Hyphema is rare in AVM but can occur; much commoner in microhemangiomatosis.) PubMed Central

13. Pupil movement: Dilation or constriction can make a looping vessel stand out, especially near the pupillary margin. ajo.com

14. Angle anatomy: A vessel that traverses the angle is easier to spot on gonioscopy, aiding diagnosis. d1xe7tfg0uwul9.cloudfront.net

15. Not a systemic malformation syndrome: Unlike big retino-cephalic AVMs (e.g., Wyburn-Mason), iris AVM is typically isolated. PubMed

16. No recognized genetic pattern: There’s no consistent hereditary pattern established for isolated iris AVM. (Supported by series reporting no systemic associations.) PubMed

17. Vessel wall remodeling over life: Normal aging may make a congenital loop more visible; that’s recognition, not new causation. (Inferred from adult discovery in series.) PubMed

18. Episcleral venous signals: Occasionally, a prominent sentinel episcleral vessel draws attention to deeper anomalies. (Described in iris vascular mimics like varix; helps differential.) EyeWiki

19. Optical contrast with iris color: Light irides can make red vessels pop visually, increasing detection. (Clinical observation consistent with slit-lamp detection literature.) PubMed

20. Mislabeling of mimics as “cause”: Microhemangiomatosis or varix are different entities that can be miscalled “AVM”; careful imaging corrects the label. morancore.utah.eduEyeWiki

---

Symptoms

Most people with an iris AVM feel nothing and see normally; the finding is incidental. When symptoms happen, they’re usually mild or relate to rare bleeding or pressure changes.

1. No symptoms at all (most common). Found during a routine exam. PubMed

2. Cosmetic notice: Some people notice a red vessel on the colored iris in strong light. PubMed

3. Glare or light sensitivity if the loop reaches close to the pupil edge. ajo.com

4. Mild eye ache or headache if intraocular pressure (IOP) is temporarily higher. (Uncommon in AVM.) PubMed

5. Blurry vision during a small hyphema (a tiny bleed into the anterior chamber). This is uncommon in AVM and much more common in microhemangiomatosis. PubMed Central

6. Seeing a fluid level or tinted vision with a larger hyphema (rare). PubMed Central

7. Tenderness after minor trauma if it triggers a small bleed (again, rare in AVM). PubMed Central

8. Floaters are unusual for iris AVM (they arise from the back of the eye) but can be reported during a bleed. (Clinical nuance; not typical.) PubMed Central

9. Anxiety from noticing a visible vessel—common and understandable.

10. Redness from unrelated irritation; the AVM can be mistaken as the cause.

11. Pulsation awareness is very uncommon, though doctors may see pulsation with high magnification. d1xe7tfg0uwul9.cloudfront.net

12. Photophobia (light sensitivity) in bright sun if the loop is near the pupil.

13. Haloes if IOP spikes (not typical in AVM but can occur with bleeding).

14. Dryness or burning from surface causes (not from AVM itself)—worth separating.

15. No change over years is common—people often report stability once they learn about it. PubMed

---

Diagnostic Tests

Doctors choose tests selectively. You won’t get all 20. The purpose is to (1) confirm it’s a benign AVM, (2) exclude look-alikes (microhemangiomatosis, varix, melanoma), (3) check for complications (bleeding, high pressure), and (4) plan treatment only if needed.

A) Physical examination

1. Slit-lamp biomicroscopy
   Core exam. Shows a prominent, tortuous iris vessel or loop. In AVM, the vessel looks large and continuous across the iris. PubMed

2. Pupil exam (light and near)
   Checks for normal reactions; AVM doesn’t usually alter pupil function but the location near the margin can make it more visible.

3. Intraocular pressure (IOP) check
   Screens for pressure spikes if bleeding or angle issues occur (rare in AVM). PubMed Central

4. Gonioscopy (angle exam, overview)
   At the slit lamp with a special lens, the clinician inspects the drainage angle to see if the vessel enters/exits there. Helps with risk assessment and surgery planning. d1xe7tfg0uwul9.cloudfront.net

5. Dilated fundus exam
   Even though AVM is in the iris, doctors look at the retina and optic nerve to rule out other vascular issues and to complete care. Optometry Times

6. Conjunctival/episcleral vessel survey
   Looks for a sentinel surface vessel or other vascular clues that might suggest a different diagnosis like varix. EyeWiki

7. Photographic documentation
   High-quality slit-lamp photos let clinicians track stability over time—important because most AVMs remain unchanged. PubMed

B) Manual/office tests

8. Detailed gonioscopy (targeted)
   A closer, quadrant-by-quadrant look for angle-traversing loops, synechiae, or tiny hemorrhage points. d1xe7tfg0uwul9.cloudfront.net

9. Applanation tonometry (Goldmann)
   The “manual” standard for accurate IOP if spikes are suspected.

10. Provocative pupil dilation (with caution)
    Doctors may dilate the pupil for full evaluation and imaging; very rarely this can reveal or precipitate a small hyphema in vascular lesions—more typical of microhemangiomatosis than AVM. PubMed Central

11. Lid eversion and surface inspection
    Rules out surface vascular lesions that could be mistaken for internal iris disease.

12. Follow-up examination interval testing
    Repeating slit-lamp, IOP, and photos over months verifies stability, which supports a benign AVM rather than a tumor.

C) Lab and pathological tests

13. Basic blood tests if bleeding is atypical
    If a patient has unusual or recurrent bleeding, clinicians may check coagulation or platelets—not for AVM itself, but to exclude a separate bleeding tendency. (General ophthalmic practice.)

14. Aqueous tap/cytology (rare)
    Only if inflammation or atypical cells are suspected (to exclude masqueraders). Not routine for straightforward AVM.

15. Histopathology (very rare)
    If surgery is ever done for another reason and tissue is available, pathology would show an artery-to-vein connection without capillaries—confirming AVM. EyeWiki

D) Electrodiagnostic tests

16. Electroretinogram (ERG)
    Tests retinal function. Usually normal in isolated iris AVM; used only if the exam suggests retinal vascular disease or a separate problem.

17. Visual evoked potential (VEP)
    Assesses the visual pathway. Again, generally not needed for an isolated iris lesion; considered only if neurologic/retinal involvement is suspected.

E) Imaging tests

18. Fluorescein angiography (FA) of the anterior segment
    Dye test that often shows early filling of the abnormal vessel and typically no leakage—a classic AVM sign helping distinguish it from vascular tumors that leak. PubMed Centralajo.com

19. Indocyanine green angiography (ICG) of the anterior segment
    Another dye test with deeper penetration that can outline iris vessels and filling patterns; useful when FA is inconclusive. PubMedJAMA Network

20. Anterior segment OCT (AS-OCT)
    Cross-sectional images show the lumen of the vessel, its depth within the iris, and relation to the angle—no needles, no dye. d1xe7tfg0uwul9.cloudfront.net

21. OCT-Angiography (AS-OCTA)
    A noninvasive way to map iris blood flow and confirm a direct arteriovenous connection; very useful in modern clinics and avoids dye side effects. BioMed CentralPubMed Central

22. Ultrasound biomicroscopy (UBM)
    High-frequency ultrasound that can show the track of the vessel and its relationship to nearby structures, especially if the cornea isn’t clear. d1xe7tfg0uwul9.cloudfront.net

23. Color slit-lamp video
    Motion recordings capture pulsation or subtle changes with pupil movement, improving recognition and teaching. (Clinical practice aid.)

24. Standard anterior segment photography (serial)
    Side-by-side comparison over time confirms stability—a key reassurance point. PubMed

25. Posterior segment OCT
    Not for the AVM itself, but to rule out retinal pathology if symptoms suggest it; ensures nothing else is missed.

Non-pharmacological treatments

1. Watchful waiting with scheduled follow-ups: Most AVMs never cause trouble. Regular exams catch early bleeding or pressure rise. Purpose/mechanism: safety surveillance. EyeWiki

2. Protective eye shield (especially during sleep) after a bleed: Prevents accidental rubbing that can restart bleeding. Mechanism: reduces mechanical trauma. EyeWiki

3. Head-of-bed elevation (≈45°) during hyphema: Lets blood settle inferiorly, protecting the cornea and drainage angle. Mechanism: gravity. EyeWiki

4. Relative rest & activity modification for a few days post-bleed: Avoids Valsalva and jarring motion. Mechanism: reduces pressure and shear on the vessel. EyeWiki

5. Avoid aspirin/NSAIDs unless essential (coordinate with your doctor): Lowers rebleed risk. Mechanism: avoids platelet inhibition. EyeWiki

6. Discuss blood thinners with the prescribing physician: Sometimes a temporary adjustment is appropriate; never stop on your own. Mechanism: balances clotting risk vs. systemic need. EyeWiki

7. Eye protection for sports/yard work: Prevents minor trauma. Mechanism: barrier.

8. Strict “no eye rubbing” rule: Direct pressure can trigger rebleeding. Mechanism: prevents vessel shear.

9. Manage blood pressure well: Smooths pressure swings that can stress fragile vessels. Mechanism: vascular stability.

10. Hydration and avoid dehydration: Especially important in people with sickle cell disease/trait. Mechanism: lowers sickling/viscosity risk. EyeWiki

11. Sunglasses / photo-protection: Reduces light sensitivity during recovery; encourages less squinting/rubbing.

12. Education on red-flag symptoms: Sudden blur, pain, halos, nausea/vomiting → urgent eye care. Mechanism: early intervention prevents damage.

13. Serial slit-lamp photography & OCT-A mapping: Objective tracking of the lesion’s stability. Mechanism: detects change early. PubMed Central

14. Gonioscopy surveillance: Watches for angle issues after hyphema (e.g., peripheral anterior synechiae). Mechanism: early glaucoma prevention. EyeWiki

15. Short-term work/school modifications: Avoid heavy lifting/straining for ~1 week post-bleed. Mechanism: lowers rebleed risk.

16. Treat constipation proactively: Prevents Valsalva during bowel movements.

17. Cough/allergy control with your clinician: Less forceful coughing/sneezing.

18. Argon laser photocoagulation of an actively bleeding point (office-based): A non-drug, targeted laser can seal the tiny culprit vessel in select cases of recurrent or active bleeding. Mechanism: coagulates the bleeding tuft. PubMedScienceDirect

19. Short-term eye-patching/shielding in selected cases: Historically studied; not routine but may be used short-term alongside head elevation. Mechanism: reduces micro-trauma and photophobia. PubMed Central

20. Pre-surgical planning precautions (if you need cataract or other eye surgery): Surgeons take extra care around the AVM to avoid bleeding (e.g., gentle manipulation, viscoelastic tamponade, hemostasis). Mechanism: risk mitigation. EyeWiki

---

Drug treatments

These do not treat the AVM itself. They treat inflammation, pain, hyphema, and IOP spikes. Dosing is typical/illustrative; your doctor will individualize it.

1. Topical corticosteroid (prednisolone acetate 1%)
   Class: steroid anti-inflammatory. Dose/time: 4–6×/day, then taper.
   Purpose: calms inflammation, helps prevent synechiae and may reduce rebleed risk.
   Mechanism: blocks inflammatory pathways. Side effects: temporary IOP rise, cataract with long use. eyerounds.orgEyeWiki

2. Cycloplegic (e.g., atropine 1% or homatropine 5%)
   Class: anticholinergic. Dose: atropine 1% 1–2×/day; homatropine 2–3×/day.
   Purpose: pain relief (ciliary spasm), prevents posterior synechiae.
   Mechanism: paralyzes ciliary muscle, dilates pupil. Side effects: blurred near vision, dry mouth, rare tachycardia. AAO

3. Topical beta-blocker (timolol 0.5%)
   Class: aqueous suppressant. Dose: typically 2×/day.
   Purpose: lowers IOP during/after hyphema.
   Side effects: fatigue, bradycardia, bronchospasm (systemic absorption). EyeWiki

4. Topical alpha-2 agonist (brimonidine 0.2%)
   Class: aqueous suppressant + uveoscleral outflow enhancer. Dose: 2–3×/day.
   Purpose: IOP control. Side effects: dry mouth, fatigue; avoid in infants. EyeWiki

5. Topical carbonic anhydrase inhibitor (dorzolamide 2% or brinzolamide 1%)
   Class: aqueous suppressant. Dose: 2–3×/day.
   Purpose: IOP control. Side effects: bitter taste, stinging. (Systemic CAIs carry sickle-cell cautions; topical is generally safer.) EyeWiki

6. Systemic carbonic anhydrase inhibitor (acetazolamide)
   Class: diuretic/IOP-lowering. Adult dosing examples: 250 mg orally every 6 h or 500 mg extended-release every 12 h when needed.
   Purpose: short-term IOP control if drops aren’t enough.
   Mechanism: reduces aqueous production. Side effects/cautions: tingling, nausea, metabolic acidosis; avoid in sickle cell due to acidosis-induced sickling risk. EyeWiki

7. Hyperosmotic agent (mannitol IV)
   Class: osmotic diuretic. Dose: per weight in emergency setting.
   Purpose: rapid IOP reduction in severe spikes. Side effects: fluid/electrolyte shifts; sickle-cell caution. EyeWiki

8. Aminocaproic acid (EACA/Amicar®)
   Class: antifibrinolytic. Common hyphema study dosing: 50–100 mg/kg orally every 4 hours for 5 days (max ~30 g/day).
   Purpose: lowers rebleed risk after hyphema.
   Mechanism: blocks plasmin → stabilizes clots. Side effects: nausea, dizziness; rare hypotension (higher doses). PubMed+1EyeWiki

9. Tranexamic acid (TXA)
   Class: antifibrinolytic (more potent than EACA). Pediatric hyphema study examples: 25 mg/kg orally every 8 h (varies; clinician-directed).
   Purpose: alternative to EACA to reduce rebleed risk in selected patients.
   Mechanism: lysine analogue; stabilizes clots. Side effects/cautions: thrombosis risk in predisposed patients; drug interactions with estrogen-containing contraceptives. Europe PMCEyeWikiMedscape Reference

10. Acetaminophen (paracetamol)
    Class: analgesic. Dose: per label/clinician. Purpose: pain relief without raising bleeding risk (unlike NSAIDs).
    Side effects: liver toxicity if overdosed. EyeWiki

---

Procedures/surgeries

1. Argon laser photocoagulation of the bleeding point
   What: Office laser to seal the tiny bleeding tuft.
   Why: For active bleeding or recurrent hyphema from a focal point. Often very effective. PubMedScienceDirect

2. Anterior-chamber washout (irrigation/aspiration)
   What: Surgical removal of layered blood from the front chamber.
   Why: Large or non-resolving hyphema, corneal blood staining, or uncontrolled IOP despite medications. EyeWiki

3. Trabeculectomy or glaucoma drainage device (as needed)
   What: Procedures to create/add a drainage pathway for aqueous humor.
   Why: Refractory high IOP (secondary glaucoma) not controlled by meds/washout. EyeWiki

4. Peripheral iridectomy (occasionally, in specific scenarios)
   What: Small piece of peripheral iris is excised.
   Why: To relieve pupillary block in a total hyphema during surgery or if indicated for angle issues. EyeWikiVagelos College of Physicians

5. Sector iridectomy/iridocyclectomy (excision of the lesion) – rare
   What: Surgical removal of the AVM-bearing iris sector ± adjacent ciliary body.
   Why: Recurrent non-laser-controlled hemorrhage, secondary glaucoma from the lesion, or diagnostic uncertainty (to rule out melanoma). PubMed CentralAAOCloudFront

---

Dietary & supplement guidance

There’s no supplement proven to shrink or cure an iris AVM. Nutrition can support overall vascular and ocular health and reduce bleeding risk, but please ask your doctor before starting anything—some products increase bleeding.

What to eat 

1. Leafy greens & colorful vegetables (spinach, kale, peppers) for antioxidants.

2. Citrus and berries for vitamin C (supports vessel wall collagen).

3. Beans, lentils, whole grains for steady blood pressure and glucose.

4. Nuts (small portions) for overall vascular health.

5. Adequate hydration to keep blood less viscous.

6. Lean proteins (fish, poultry, tofu) for tissue repair.

7. Low-salt cooking to keep bp stable.

8. Olive-oil-based cooking instead of trans fats.

9. Regular meals to avoid bp swings.

10. Limit alcohol (binge drinking can worsen bleeding risk).

What to avoid or be cautious with:

• Aspirin/NSAIDs unless prescribed (bleeding risk).

• Herbal blood thinners (e.g., ginkgo, high-dose garlic, ginseng, high-dose fish oil).

• Excess salt, energy drinks, and very high caffeine (bp spikes).

• Smoking (vessel dysfunction).

If your clinician approves supplements, typical “supportive” options (not treatments) 

• Vitamin C (e.g., 250–500 mg/day) – supports collagen in vessel walls; too much can upset the stomach.

• Magnesium (100–200 mg/day) – smooths vascular tone; may loosen stools.

• CoQ10 (100 mg/day) – general mitochondrial support; interacts with blood thinners.

• Lutein/zeaxanthin (10 mg/2 mg daily) – macular antioxidants (eye health broadly); not AVM-specific.

• Vitamin D (per level, often 800–2000 IU/day) – general immune/vascular health; check levels.

• B-complex – supports red-cell/nerve metabolism.

• Potassium from food – supports bp if kidneys are healthy.

• Flavonoid-rich foods (cocoa, berries) – endothelial support.

• Avoid “pro-bleeding” botanicals (as above).
  (Again: these are general wellness ideas, not AVM therapies; clear them with your doctor—especially if you’ve had a bleed or use anticoagulants.)

---

Regenerative / stem-cell drugs

• There are no approved immune-boosting, regenerative, gene, or stem-cell drugs that treat iris AVM.

• Anti-VEGF drugs help neovascular iris disease, but iris AVM is not neovascularization—so anti-VEGF is not a standard treatment here.

• Stem-cell and gene therapies in ophthalmology focus on retina/cornea, not iris AVMs.

• Any such use in iris AVM would be experimental and not recommended outside a regulated clinical trial.

Sticking to observation, hyphema care, IOP control, and targeted laser/surgery when indicated is the evidence-based path. EyeWiki

---

Ways to prevent complications

1. Wear eye protection for sports/DIY.

2. No eye rubbing; use preservative-free tears for irritation instead.

3. Manage blood pressure and follow your primary-care plan.

4. Avoid NSAIDs/aspirin unless your doctor needs you on them. EyeWiki

5. Limit alcohol and avoid binges.

6. Stay hydrated; avoid extreme dehydration.

7. Avoid heavy lifting/straining for a week after any bleed; treat constipation.

8. Quit smoking; keep diabetes (if present) well controlled.

9. Head elevation and shield for sleep during hyphema recovery. EyeWiki

10. Keep follow-ups (including IOP checks) exactly as scheduled.

---

When to see a doctor urgently

• Sudden blur, new floaters, or you see blood in the front of the eye.

• Eye pain, headache, halos, nausea/vomiting (possible high IOP).

• After any eye injury, even if minor.

• Before elective eye surgery (let the surgeon know you have an iris AVM).

• If you’re on blood thinners and notice any eye bleeding.

For hyphema, early IOP monitoring, head elevation, protective measures, and appropriate drops are key. EyeWiki

---

FAQs

1. Is iris AVM cancer?
   No. It’s a benign vascular malformation. EyeWiki

2. Can it go away on its own?
   It usually stays the same size/appearance for life. Most never cause symptoms. EyeWiki

3. What’s the biggest risk?
   Hyphema (bleeding into the front chamber) and a temporary rise in eye pressure. EyeWiki+1

4. How is bleeding treated?
   Head elevation, protective shield, steroids and cycloplegics, pressure-lowering drops, sometimes antifibrinolytics and, if needed, washout. EyeWiki

5. Can a laser fix it?
   If a single spot is bleeding, argon laser can seal it. Otherwise, most lesions are just watched. PubMed

6. Do I need surgery?
   Rarely. Surgery (e.g., sector iridectomy) is reserved for recurrent, stubborn bleeds or diagnostic uncertainty. PubMed Central

7. Will I go blind?
   Very unlikely if complications are handled promptly. Prognosis is excellent in most people. EyeWiki

8. Can I exercise?
   Yes, but avoid heavy straining for about a week after any bleed; otherwise follow your doctor’s advice.

9. Are NSAIDs safe?
   They can increase rebleeding risk after hyphema. Prefer acetaminophen for pain unless your doctor says otherwise. EyeWiki

10. Do eye drops cure AVM?
    No. Drops manage inflammation and eye pressure, not the AVM itself. EyeWiki

11. Can I fly?
    Generally yes if you’re stable and no active hyphema. Ask your doctor right after a bleed.

12. Is it related to diabetes or other conditions?
    Iris AVM itself is typically isolated; however, some other iris vascular anomalies can associate with systemic disease. EyeWiki

13. What scans will I get?
    Slit-lamp, angiography, AS-OCT/OCT-A, sometimes UBM. PubMed Central

14. Can it be on both eyes?
    It’s usually unilateral; bilateral cases are uncommon. (Most series report unilateral presentation.) JAMA Network

15. Will cataract surgery be risky?
    Surgeons take extra precautions around the AVM; with planning, cataract surgery can be done safely. EyeWiki

Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical  history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.

The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members

Last Updated: August 09, 2025.

PDF Document For This Disease Conditions References